Thinking About the Box: Considerations for Transport of Investigational Products
Advarra
OCTOBER 26, 2023
Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines. The containment must then prevent spills or leaks if the IP is dropped. Size matters.
52 
Let's personalize your content